Phosphorylated FADD alters the expression of cell cycle regulatory proteins (e.g., Cyclin D1 and Cyclin B1) by activating NF-κB signaling pathway, thereby mediating the G2/M transition of cancer cells. Here, FADD is linked to cancer.